医保直接结算
Search documents
减轻“跑腿”负担!四川省本级参保职工门诊计生手术费直接结算
Xin Lang Cai Jing· 2026-01-02 11:15
定额支付标准如下—— 为切实保障参保人员权益,减轻参保人员"跑腿"负担,从1月1日起,四川开展门诊计划生育手术费在定 点医疗机构"一站式""一单制"直接结算。结算范围包括:省本级参保职工在省本级定点医疗机构门诊, 实施放置(或取出)宫内节育器、流产术、引产术、绝育及复通等计划生育手术发生的医疗费,实行联 网定额支付。参保人员只需支付个人负担的医疗费,应由医保基金支付的费用,由省医疗保障事务中心 与定点医疗机构另行结算。 川观新闻记者 刘春华 (1)放置宫内节育器,每例157元; (2)取出宫内节育器,每例160元; (3)长效缓释避孕皮下埋植剂植入术,每例132元; (4)长效缓释避孕皮下埋植剂取出术,每例148元; (5)输卵管结扎术,每例317元; (6)输精管结扎术,每例79元; (7)人工流产术,每例269元; (8)药物流产,每例129元(药流不全清宫加收47元); (9)中期孕引产,每例523元; (10)输卵管结扎后的复通术,每例993元; (11)输精管结扎后的复通术,每例993元。 【未经授权,严禁转载!联系电话028-86968276】 ...
报告:药品流通企业回款周期增至154天
Di Yi Cai Jing· 2025-12-09 10:29
12月8日,商务部发布《2024年药品流通行业运行统计分析报告》(以下简称《报告》)。报告称,2024年,中国医药商业协会对 31 个省(自治区、直辖 市)630 家药品批发企业应收账款情况开展典型调查。数据显示,对医疗机构应收账款回款天数平均154天,比2023年又拉长了两天。 专家指出药企应收账款时间长的三大原因 2024年,我国药品流通企业对医疗机构的应收账期回款天数进一步拉长,整个行业的现金流继续承压。 今年初,国家医保局启动了"三结算",即医保与定点医药机构即时结算,与医药企业直接结算,探索商保、慈善互助等与基本医保同步结算。目前,全国所 有统筹地区已全部实现医保基金即时结算,国家医保局将持续扩大即时结算资金规模和医疗机构覆盖范围,持续加快医保资金拨付,同时结合集采优化措 施,加快推进医保与医药企业直接结算。 "药企应收账款时间延长是多种因素共同作用的结果,国家医保局推行的直接结算政策对改善这一现状有积极作用,也可通过合理调整医保支付政策、建 立'预付金+周转金'双重保障制度等方式解决医院现金流紧张问题。"邓勇说。 从实施效果来看,江西创新推行周转金制度,建立预付货款和医院回款直接结算模式,将企业货 ...
“医保直接结算”后,医院难摆脱现金流焦虑
Hu Xiu· 2025-10-10 03:03
Core Viewpoint - The implementation of direct settlement between medical insurance and pharmaceutical companies has raised significant cash flow concerns for hospitals, as the new model alters the traditional payment cycle and may exacerbate existing financial pressures [1][3][5]. Group 1: Cash Flow Anxiety - Hospitals are experiencing heightened cash flow anxiety due to ongoing reforms in medical insurance payment methods and adjustments in medical service pricing, leading to reduced revenues and difficulties in payroll [2][5]. - The transition to direct settlement has caused hospitals to worry about the potential disruption of cash flow, which has historically been a crucial part of their financial stability [3][5]. - The average accounts receivable days for hospitals from pharmaceutical companies is reported to be 152 days, indicating a significant delay in cash inflow [6]. Group 2: Direct and Instant Settlement Policies - The direct settlement policy, which allows local medical insurance departments to settle payments with pharmaceutical companies directly, aims to shorten the payment cycle to within one month [1][3]. - The introduction of the prepayment system by the National Medical Insurance Administration in November 2024 is intended to alleviate cash flow pressures by allowing hospitals to apply for advance payments from the insurance fund [10][11]. - The prepayment system has been criticized for its stringent application requirements, making it difficult for hospitals to access these funds, which were previously more readily available under the old turnover fund system [11][12]. Group 3: Operational Adjustments in Hospitals - Hospitals are adjusting their procurement strategies due to cash flow constraints, often reducing inventory levels to avoid the risk of stockpiling unsold medications [8][10]. - The pressure to maintain timely payments to pharmaceutical companies has led some hospitals to consider taking loans to meet their obligations, which poses compliance risks [17]. - The implementation of daily or weekly settlement trials in some regions has been viewed positively by hospitals, as it provides more immediate cash flow without significantly increasing administrative burdens [25][24]. Group 4: Future Outlook - The goal of achieving instant settlement for medical insurance funds with designated medical institutions is set for 2025, with a target of 80% of regions implementing this by then [23]. - Concerns remain regarding the potential increase in operational workload for hospitals due to more frequent settlements, although initial feedback suggests that the benefits of improved cash flow outweigh these concerns [24][25].